NextGeM Inc.

Business
Business

Business

Business Details

"Development of Next Generation of Medicine / Therapies using Stem Cells"

Tissue stem cells have a special ability to support lifetime cells regeneration.

Stem cells are the only cells that possess self-renewal ability and pluripotency. Due to these special characteristics, stem cells are being developed for the treatment of difficult and rare diseases which were could not be treated well so far. On the other hand, the actual and real characteristics of stem cells has not been sufficiently investigated yet. It is still difficult to distinguish stem cells from other cell types, and to understand even to maintain their characteristics, thus actual clinical application of stem cells is very limited. In NextGem Inc., we utilize an advanced proprietary cell analysis technology to maximize the potential of stem cells and aim to bridging the potential application of stem cells with next-generation medical technology for better future of patients management.

Establish core technology for medical application of stem cell analysis and medical application.

We are developing core technologies that are important in the medical application of rare cells including stem cells.

Our technology which was developed at Stanford University - United States, is a technology to identify and isolate long-term hematopoietic stem cells, a very small portion of hematopoietic stem cells with the proportion of around 1 cell in 100,000 cells of mouse bone marrow cells. This technology was published already in Nature scientific journal, and it is applicable for the identification and isolation of various other rare cells in human body. At the same time, we are also developing the next generation technology of rare cell identification and isolation in combination with our proprietary technology. The future mission is to bring our technology as a fundamental technology to accelerate the understanding of many diseases including personalized medicine, rare diseases, refractory diseases and development of their therapeutics modalities.

Currently, we utilize these core technologies to develop several products and services that promote stem cell research and its medical applications.

  • Development of high efficiency stem cells identification and purification methods
  • Development of stem cells maintenance and amplification methods
  • Development of next generation transplantation methods using optimized stem cells

CLOSE